A team of international scientists from the universities of Glasgow and Oxford and the Rosalind Franklin Institute have identified key cellular factors that are crucial for the infection of SARS-CoV-2.
Bio-Rad’s Coronavirus Ag Rapid Test, an antigen test used to detect the nucleocapsid protein antigen in SARS-CoV-2, offers new flexibility in detecting SARS-CoV-2 and now includes a quality control (QC) swab kit.
The British Society for Microbial Technology (BSMT) webinar series of lectures proved a huge success. The four-day virtual conference was recorded, and can now be viewed via the article on page 15 of the May digital issue of Pathology in Practice.
EU-OSHA has joined forces with the European Centre for Disease Prevention and Control (ECDC) to explore the use of rapid antigen diagnostic tests for SARS-CoV-2, the virus that causes COVID-19, in occupational settings.
Over the past 12 months, Menarini Diagnostics has brought to market a range of new and innovative technologies to aid in the global fight against Covid-19. The company is now pleased to support this week’s BSMT webinar series on COVID-19.
The British Society for Microbial Technology (BSMT) webinar series of lectures proved a huge success. The four-day virtual conference was recorded, so registrants can still view the lectures after the event when convenient to do so.
This British Society for Microbial Technology (BSMT) webinar series of lectures is recorded, so registrants can view either in real time or after the event when convenient to do so.
The VITROS COVID-19 Total and IgG Antibody Tests and VITROS SARS-CoV-2 Antigen Test from Ortho Clinical Diagnostics help to identify an active or previous infection, together with PCR and clinical history.
A team of scientists at the University of Glasgow has identified two known cases of human-to-cat SARS-CoV-2 transmission in the UK.
The Native Antigen Company has launched its SARS-CoV-2 Neutralisation Assay Development Kit, which can be used to identify and qualitatively assess the ability of antibodies to neutralise SARS-CoV-2-receptor binding.
Bio-Rad Laboratories has launched the SARS-CoV-2 Variant RT-PCR assays, which can detect the variants of concern, including P.1, B.1.351, and B.1.1.7.
The BSMT has confirmed that Professor Sheena Cruikshank (University of Manchester) will speak on 'From Variola to COVID-19: the Development of Modern Vaccines'. Click on this news item for the link to register for this FREE-to-attend webinar series.
The British Society for Microbial Technology event takes place on Tuesday 11 May to Friday 14 May 2021. Click on this news item for the link to register for this FREE-to-attend webinar series.
Mologic, a developer of lateral-flow and rapid diagnostics, has announced its rapid antigen self-test for SARS-CoV-2 has been selected by the Rapid Acceleration of Diagnostics (RADx) initiative launched by the US National Institutes of Health (NIH).
Avacta Group, the developer of cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms, has announced a global distribution agreement with ABCAM to sell the SARS-CoV-2 research ELISA Affimer reagents.
The BSMT Virtual Conference on COVID-19 is a FREE-to-attend event that takes place on Tuesday 11 May to Friday 14 May 2021. Click on this news item for the link to register for the webinar series.
Thermo Fisher Scientific and Artificial, a developer of flexible automation software, have announced a technology collaboration to develop an integrated and comprehensive software platform for Thermo Fisher’s standardised COVID-19 Testing Platform.